Abstract:Gene therapy has gained increasing attention as an alternative to pharmacotherapy for treatment of various diseases. The extracellular and intracellular barriers to gene delivery necessitate the use of gene vectors which has led to the development of myriads of gene delivery systems. However, many of these gene delivery systems have pitfalls such as low biocompatibility, low loading efficiency, low transfection efficiency, lack of tissue selectivity and high production costs. Herein, we report the development of a new series of short cationic amphiphilic peptides with anticancer activity for selective delivery of small interfering RNA (siRNA) and antisense oligodeoxynucleotides (ODNs) to cancer cells. The peptides consist of alternating dyads of hydrophobic (isoleucine (I) or leucine (L)) and hydrophilic (arginine (R) or lysine (L)) amino acids. The peptides exhibited higher preference for transfection of HCT 116 colorectal cancer cells compared to human dermal fibroblasts (HDFs) and induced higher level of gene silencing in the cancer cells. The nucleic acid complexation and transfection efficiency of the peptides was a function of their secondary structure, their hydrophobicity and their C-terminal amino acid. The peptides containing L in their hydrophobic domain formed stronger complexes with siRNA and successfully delivered it to the cancer cells but were unable to release their cargo inside the cells and therefore could not induce any gene silencing. On the contrary, the peptides containing I in their hydrophobic domain were able to release their associated siRNA and induce considerable gene silencing in cancer cells. The peptides exhibited higher selectivity for colorectal cancer cells and induced less gene silencing in fibroblasts compared to the lipid-based commercial transfection reagent DharmaFECT™ 1. The results from this study can serve as a tool for rational design of new peptide-based gene vectors for high selective gene delivery to cancer cells.

Construction and Characterization of Crgd-Modified 9-Arginine Peptide As A Novel Vector for Targeted Sirna Delivery

Construction and Biological Evaluation of a Novel Integrin Ανβ3-Specific Carrier for Targeted Sirna Delivery in Vitro

Noninvasive Imaging of C(Rgd)(2)-9r As A Potential Delivery Carrier for Transfection of Sirna in Malignant Tumors

Systemic Administration of Sirna Via Crgd-Containing Peptide

Systemic and Tumor-Targeted Delivery of Sirna by Cyclic NGR and Isodgr Motif-Containing Peptides.

Tumor-Targeted In Vivo Gene Silencing Via Systemic Delivery Of Crgd-Conjugated Sirna

In Vitro and in Vivo Therapeutic Sirna Delivery Induced by a Tryptophan-Rich Endosomolytic Peptide

Non-Cationic RGD-Containing Protein Nanocarrier for Tumor-Targeted siRNA Delivery

A Novel Peptide for Efficient Sirna Delivery in Vitro and Therapeutics in Vivo.

Biodegradable Stearylated Peptide with Internal Disulfide Bonds for Efficient Delivery of Sirna in Vitro and in Vivo.

An RGD-modified MRI-visible Polymeric Vector for Targeted Sirna Delivery to Hepatocellular Carcinoma in Nude Mice.

Construction Of A Tumor Cell-Targeting Non-Viral Gene Delivery Vector With Polyethylenimine Modified With Rgd Sequence-Containing Peptide

Construction of a Targeting Nanoparticle of 3′,3″-Bis-peptide-sirna Conjugate/Mixed Lipid with Postinserted DSPE-PEG2000-cRGD

Data from Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles

Targeted Gene Silencing Using Rgd-Labeled Chitosan Nanoparticles

A Multifunctional Nanoparticle Constructed with a Detachable Albumin Outer Shell and a Redox-Sensitive Inner Core for Efficient Sirna Delivery to Hepatocellular Carcinoma Cells

Self-assembly Nanomicelles Based on Cationic Mpeg-Pla-b-polyarginine(r15) Triblock Copolymer for Sirna Delivery.

Feasibility of Crgd Conjugation at 5-Antisense Strand of Sirna by Phosphodiester Linkage Extension

Rationally Designed Cationic Amphiphilic Peptides for Selective Gene Delivery to Cancer Cells.

Optimization of a siRNA Carrier Modified with a pH-Sensitive Cationic Lipid and a Cyclic RGD Peptide for Efficiently Targeting Tumor Endothelial Cells

Worm-Like Biomimetic Nanoerythrocyte Carrying Sirna for Melanoma Gene Therapy